E-LIB Suche - Ergebnisse für: Levin, May

1

Age-differentiated incentives for adaptive behavior during ..:

Arthur, Ronan F. ; Levin, May ; Labrogere, Alexandre..
PLOS Computational Biology. 19 (2023) 9 - p. e1011217 , 2023

Link: https://doi.org/10.1371/..

2

Folylpolyglutamate synthetase mRNA G-quadruplexes regulate ..:

Stark, Michal ; Levin, May ; Ulitsky, Igor.
BMC Biology. 21 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

3

Deciphering molecular mechanisms underlying chemoresistance..:

Levin, May ; Stark, Michal ; Ofran, Yishai.
Cancer Cell International. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

4

Surmounting Cytarabine-resistance in acute myeloblastic leu..:

Levin, May ; Stark, Michal ; Berman, Bluma.
Cell Death & Disease. 10 (2019) 6 - p. , 2019

Link: https://doi.org/10.1038/..

5

The JmjN domain as a dimerization interface and a targeted ..:

Levin, May ; Stark, Michal ; Assaraf, Yehuda G.
Oncotarget. 9 (2018) 24 - p. 16861-16882 , 2018

Link: https://doi.org/10.18632..

6

Folylpolyglutamate synthetase mRNA G-quadruplexes regulate ..:

Stark, Michal ; Levin, May ; Ulitsky, Igor.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889130/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Machine Learning Strategies for Improved Phenotype Predicti..:

Bonet, David ; Levin, May ; Montserrat, Daniel Mas.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614800/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Surmounting Cytarabine-resistance in acute myeloblastic leu..:

Levin, May ; Stark, Michal ; Berman, Bluma.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525253/. , 2019

Link: http://www.ncbi.nlm.nih...

9

Clinical nutrition guidelines of the French Speaking Societ..:

Senesse, Pierre ; Bachmann, Patrick ; Bensadoun, René-Jean...
Digestive and Liver Disease. 46 (2014) 8 - p. 667-674 , 2014

Link: https://doi.org/10.1016/..

10

Nutrition chez le patient adulte atteint de cancer : introd..:

Senesse, Pierre ; Bachmann, Patrick ; Bensadoun, René Jean...
Nutrition Clinique et Métabolisme. 26 (2012) 4 - p. 149-150 , 2012

Link: https://doi.org/10.1016/..

11

Pamidronate infusions as single-agent therapy for bone meta..:

Tyrrell, C.T. ; Bruning, P.P. ; May-Levin, F....
European Journal of Cancer. 31 (1995) 12 - p. 1976-1980 , 1995

Link: https://doi.org/10.1016/..

12

Is the negative prognostic value of high oestrogen receptor..:

Sancho-Garnier, H. ; Delarue, J.-C. ; Mouriesse, H....
European Journal of Cancer. 31 (1995) 11 - p. 1851-1855 , 1995

Link: https://doi.org/10.1016/..

13

Breast carcinoma: The prognostic relevance of ER.R factor i..:

Gotteland, M. ; May, E. ; May-Levin, F....
European Journal of Cancer. 30 (1994) - p. S20 , 1994

Link: https://doi.org/10.1016/..

14

Non comparative multi centre open trial in patients with br..:

Tyrrell, C.J. ; Bruning, P.F. ; May-Levin, F...
The Breast. 2 (1993) 3 - p. 202-203 , 1993

Link: https://doi.org/10.1016/..

15

Second and third line hormonotherapy in advanced post-menop..:

Garcia-Giralt, E. ; Ayme, Y. ; Carton, M....
Breast Cancer Research and Treatment. 24 (1992) 2 - p. 139-145 , 1992

Link: https://doi.org/10.1007/..